Informal Request for ATI Records Previously Released

Organization: Health Canada

Year: 2024

Month: January

Request Number: A-2023-000847

Request Summary: Adverse Drug Reactions (ADRs) for Tavneos. Report numbers: E2B_06476280, E2B_06503137. ADR for Rexulti: E2B_06469898. ADR for Rexulti. Report number: E2B_06469898. ADR for Rexulti and Aripiprazole. Report number: E2B_06501539. ADRs for Ablify Maintena. Report numbers: 001048638, 001048913, 001050459, 001050957, 001051278. ADR for Aripiprazole. Report number: E2B_06507796.

Disposition: Disclosed in part

Number of pages: 121

Date modified: